Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BIOATLA INC by BioAtla, Inc. (OTCQB:BCAB) through any online brokerage.
There are no as such competitors for BIOATLA INC by BioAtla, Inc..
BIOATLA INC by BioAtla, Inc. has a consensus price target of $150.00.
The stock price for BIOATLA INC by BioAtla, Inc. (OTCQB: BCAB) is $1.3 last updated September 30, 2026 at 3:59 PM EDT.
There are no upcoming dividends for BIOATLA INC by BioAtla, Inc..
BIOATLA INC by BioAtla, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for BIOATLA INC by BioAtla, Inc..
BIOATLA INC by BioAtla, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.